International Stem Cell CORP

ISCO · OTC · SIC 2834: Pharmaceutical Preparations
280
SEC Filings

Business Summary

PART I Business Overview International Stem Cell Corporation (sometimes referred to herein as ISCO, the Company, we, us, or our) is a clinical stage biotechnology company focused on therapeutic and biomedical product development with multiple long-term therapeutic opportunities and two revenue-generating businesses offering potential for increased future revenue. We currently have no revenue generated from our principal operations in therapeutic and clinical product development through research ...

Next Earnings

Q2 FY2026 — expected 2026-09-16

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionISCOdiscussed_in_filing Healthcare & Bio
topic_mentionISCOdiscussed_in_filing Healthcare & Bio
topic_mentionISCOdiscussed_in_filing Healthcare & Bio
topic_mentionISCOdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001193125-26-131723EDGAR45K words
2025-03-282024-12-310000950170-25-046745EDGAR—
2024-03-282023-12-310000950170-24-038092EDGAR—
2023-03-302022-12-310000950170-23-010977EDGAR—
2022-03-292021-12-310001564590-22-012221EDGAR—
2021-03-302020-12-310001564590-21-016653EDGAR—
2020-06-012019-12-310001564590-20-027718EDGAR—
2019-04-152018-12-310001564590-19-011540EDGAR—
2018-04-092017-12-310001564590-18-007802EDGAR—
2017-03-312016-12-310001564590-17-005854EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001193125-25-280090EDGAR22K words
2025-08-142025-06-300001193125-25-180761EDGAR—
2025-05-142025-03-310000950170-25-071338EDGAR—
2024-11-132024-09-300000950170-24-126268EDGAR—
2024-08-132024-06-300000950170-24-096128EDGAR—
2024-05-142024-03-310000950170-24-059478EDGAR—
2023-11-132023-09-300000950170-23-062890EDGAR—
2023-08-112023-06-300000950170-23-041762EDGAR—
2023-05-122023-03-310000950170-23-021741EDGAR—
2022-11-142022-09-300001564590-22-037618EDGAR—
2022-08-122022-06-300001564590-22-029273EDGAR—
2022-05-132022-03-310001564590-22-020039EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2025-11-180001683168-25-008521EDGAR1K words
2025-09-160001683168-25-007018EDGAR—
2024-09-170001683168-24-006436EDGAR—
2023-09-180001683168-23-006510EDGAR—
2023-06-210001683168-23-004312EDGAR—
2023-03-160001683168-23-001546EDGAR—
2022-09-160001683168-22-006449EDGAR—
2022-06-140001683168-22-004317EDGAR—
2022-04-290001683168-22-003021EDGAR—
2022-03-030001564590-22-008509EDGAR—

280 total filings indexed. 248 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001355790
TickerISCO
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f8a0d325963c49fb9190ba58c3e02ab25f07cef516d550ef865d577c0e119185
parent: 5c9323164ca481f14ecb223b10316c251b4137f59d33ba093b1185f10ab336f3
content hash: 50883eb9d5d4280f9bc77359c8e115ff513de0686e34aeb9ae5b73064c5f7f9c
signed: 2026-04-13T04:45:45.441Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf